New Clinical Guidelines for the Management of Hypertension
19.95
About the Course:
This course will help distinguish between primary and secondary hypertension, characterize the different stages of high blood pressure and identify factors implicated in the development of hypertension.
Learning Objectives
After completing this course, the learner should be able to:
Katie Ingersoll-Blair, Pharm.D., R.Ph. is a community pharmacist, consultant and freelance writer who specializes in pharmacy education. She has performed freelance work writing and editing practice questions for various pharmacy technician exams, as well as has written and revised continuing education programs for pharmacists and pharmacy technicians. She has also written for Natural Standard, summarizing research studies on dietary supplements, and working on the company blog. Dr. Ingersoll-Blair graduated from Northeastern University in Boston, Massachusetts in 2009 with a Doctor of Pharmacy degree.
How to receive credit:
Colibri Healthcare, LLC is accredited by the Accreditation Council of Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. (Provider #0607).
This course will help distinguish between primary and secondary hypertension, characterize the different stages of high blood pressure and identify factors implicated in the development of hypertension.
Learning Objectives
After completing this course, the learner should be able to:
- Characterize the different stages of high blood pressure including elevated blood pressure, Stage 1 hypertension, Stage 2 hypertension, and hypertensive crisis.
- Distinguish between primary (also known as essential) and secondary hypertension.
- Describe two myths associated with the symptoms of hypertension.
- Name three factors implicated in the development of hypertension.
- Identify three components of the DASH diet.
- Name one antihypertensive agent identified by JNC 8 for initial treatment of black hypertensive patients.
- List three class side effects associated with the use of beta blockers.
- Identify one advantage of combination drug product use to treat hypertension.
- Describe one potentially neurologic abnormality that is associated with a hypertensive emergency.
Katie Ingersoll-Blair, Pharm.D., R.Ph. is a community pharmacist, consultant and freelance writer who specializes in pharmacy education. She has performed freelance work writing and editing practice questions for various pharmacy technician exams, as well as has written and revised continuing education programs for pharmacists and pharmacy technicians. She has also written for Natural Standard, summarizing research studies on dietary supplements, and working on the company blog. Dr. Ingersoll-Blair graduated from Northeastern University in Boston, Massachusetts in 2009 with a Doctor of Pharmacy degree.
How to receive credit:
- A minimum test score of 75 percent is needed to obtain a credit.
Activity Type - Knowledge-based
Target Audience - Pharmacists, Pharmacists Technicians
Disclosures:
- Contact hours will be awarded through the expiration date.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record of completion submitted through CPE Monitor and to the NABP.
- Through our review process, Elite ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Elite's policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
Colibri Healthcare, LLC is accredited by the Accreditation Council of Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. (Provider #0607).